Inventiva Sa

NASDAQ:IVA USA Biotechnology
Market Cap
$898.69 Million
Market Cap Rank
#10540 Global
#4866 in USA
Share Price
$6.16
Change (1 day)
+1.32%
52-Week Range
$2.82 - $7.15
All Time High
$19.00
About

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat … Read more

Inventiva Sa (IVA) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2025: 5.765x

Based on the latest financial reports, Inventiva Sa (IVA) has a cash flow conversion efficiency ratio of 5.765x as of June 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-53.89 Million) by net assets ($-9.35 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Inventiva Sa - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Inventiva Sa's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Inventiva Sa Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Inventiva Sa ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Inventiva Sa (2013–2024)

The table below shows the annual cash flow conversion efficiency of Inventiva Sa from 2013 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $-106.65 Million $-85.93 Million 0.806x -68.38%
2023-12-31 $-32.03 Million $-81.61 Million 2.548x +357.90%
2022-12-31 $45.48 Million $-44.93 Million -0.988x -84.33%
2021-12-31 $88.87 Million $-47.63 Million -0.536x -94.85%
2020-12-31 $111.21 Million $-30.59 Million -0.275x +59.92%
2019-12-31 $41.39 Million $-28.40 Million -0.686x -23.57%
2018-12-31 $61.60 Million $-34.21 Million -0.555x -109.07%
2017-12-31 $64.01 Million $-17.00 Million -0.266x +36.15%
2016-12-31 $35.72 Million $-14.86 Million -0.416x -27.24%
2015-12-31 $42.77 Million $-13.98 Million -0.327x -13.88%
2014-12-31 $51.51 Million $-14.79 Million -0.287x -5.83%
2013-12-31 $59.01 Million $-16.01 Million -0.271x --